HEMA : Summary for HEMACARE CORP - Yahoo Finance

U.S. Markets close in 2 hrs 32 mins

HemaCare Corporation (HEMA)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.700.00 (0.00%)
As of 2:17PM EST. Market open.
People also watch
HMGNCVASLCARCNCTEMIS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.70
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume1,528
Market Cap7.23M
Beta0.40
PE Ratio (TTM)-43.75
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire14 days ago

    HemaCare and OneBlood Announce Innovative Partnership

    HemaCare Corporation , a leading provider of human-derived primary blood cells and tissues for biomedical research, has announced a strategic partnership with and investment by a wholly-owned subsidiary of OneBlood, Inc., a not-for-profit blood center based in Florida.

  • Business Wire15 days ago

    HemaCare to Present at Phacilitate Cell & Gene Therapy World 2017

    HemaCare Corporation , a leader in cell and tissue collection, processing, and cell therapy solutions, will be presenting and hosting a roundtable discussion at Phacilitate Cell & Gene Therapy World to be held at the Hyatt Regency Miami in Florida, January 17-20.

  • Business Wire3 months ago

    HemaCare Signs Distribution Agreement with Korea-Based Partner

    HemaCare Corporation , a leader in cell and tissue collection, processing, and cell therapy solutions, has expanded its global capabilities through a strategic distribution agreement in Korea with Seoul-based AccuResearch Korea, Inc.